the potent in vitro activity and high stability to beta-lactamase of moxalactam corresponded to lower ed50 ( 50 % effective doses ) required against intraperitoneal infections in mice due to various bacteria resistant to cefazolin , cefoxitin , or cefotiam .
C0597979
beta-lactamase
C0004611
bacteria